Latest Period
Q4 2025
Security Snapshot
Beta Bionics, Inc. - Common Stock (BBNX) Institutional Ownership
CUSIP: 08659B102
13F Institutional Holders and Ownership History from Q1 2025 to Q1 2026
Institutions Reporting
158
Shares (Excl. Options)
47,221,203
Price
$30.47
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common Stock
- Symbol
- BBNX on Nasdaq
- Shares outstanding
- 44,038,904
- Price per share
- $8.86
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 47,221,203
- Total reported value
- $1,439,219,439
- % of total 13F portfolios
- 0%
- Share change
- -1,176,529
- Value change
- +$22,363,225
- Number of holders
- 158
- Price from insider filings
- $8.86
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- BBNX - Beta Bionics, Inc. - Common Stock is tracked under CUSIP 08659B102.
- 158 institutions reported positions in Q4 2025.
- 10 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 158 to 19 between Q4 2025 and Q1 2026.
- Reported value moved from $1,439,219,439 to $6,658,595.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 158 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 08659B102?
CUSIP 08659B102 identifies BBNX - Beta Bionics, Inc. - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 08659B102:
Significant Owners of Beta Bionics, Inc. - Common Stock (BBNX) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| EVENTIDE ASSET MANAGEMENT, LLC | 11% | $52,456,043 | 4,857,041 | Eventide Asset Management, LLC | 31 Jan 2025 | |||
| Farallon Capital Partners, L.P. | 9.9% | +2% | $88,211,589 | +$3,544,640 | 4,379,920 | +4.2% | Dapice Joshua J. | 31 Dec 2025 |
| Zone Healthcare Holdings, LLC | 9.9% | +25% | $85,717,590 | +$17,618,729 | 4,313,920 | +26% | Dapice Joshua J. | 30 Sep 2025 |
| MORGAN STANLEY | 8.6% | +26% | $74,305,196 | +$16,109,185 | 3,739,567 | +28% | Morgan Stanley | 30 Sep 2025 |
| Sands Capital Life Sciences Pulse Fund II, L.P. | 8.2% | +13% | $48,410,732 | +$5,636,946 | 3,570,113 | +13% | Sands Capital Life Sciences Pulse Fund II. L.P. | 30 Jun 2025 |
| BlackRock, Inc. | 6.4% | $55,215,708 | 2,778,764 | BlackRock, Inc. | 30 Sep 2025 | |||
| RTW INVESTMENTS, LP | 5.7% | -24% | $50,350,000 | -$16,109,362 | 2,500,000 | -24% | RTW Investments, LP | 31 Dec 2025 |
| Point72 Asset Management, L.P. | 5.2% | $34,190,043 | 2,290,023 | Point72 Asset Management, L.P. | 18 Feb 2026 | |||
| PERCEPTIVE ADVISORS LLC | 3.7% | $21,609,324 | 1,593,608 | Perceptive Advisors LLC | 31 Mar 2025 | |||
| MILLENNIUM MANAGEMENT LLC | 1.8% | -70% | $15,835,993 | -$29,602,207 | 796,964 | -65% | Millennium Management LLC | 30 Sep 2025 |
As of 31 Dec 2025, 158 institutional investors reported holding 47,221,203 shares of Beta Bionics, Inc. - Common Stock (BBNX). This represents 107% of the company’s total 44,038,904 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Beta Bionics, Inc. - Common Stock (BBNX) together control 90% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| EVENTIDE ASSET MANAGEMENT, LLC | 11% | 4,994,728 | +0.76% | 2.4% | $152,232,937 |
| FARALLON CAPITAL MANAGEMENT LLC | 9.8% | 4,313,920 | 0% | 0.76% | $131,445,142 |
| Sands Capital Alternatives, LLC | 8.1% | 3,570,113 | 0% | 21% | $108,781,343 |
| MORGAN STANLEY | 7.9% | 3,459,453 | -8% | 0.01% | $105,409,532 |
| BlackRock, Inc. | 6.6% | 2,913,920 | +4.8% | 0% | $88,787,143 |
| Soleus Capital Management, L.P. | 5.8% | 2,534,565 | -35% | 3.3% | $77,228,196 |
| RTW INVESTMENTS, LP | 5.7% | 2,500,000 | -24% | 0.76% | $76,175,000 |
| VANGUARD GROUP INC | 5% | 2,218,238 | +0.09% | 0% | $67,589,712 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 3% | 1,327,100 | 0.07% | $40,436,737 | |
| Omega Fund Management, LLC | 3% | 1,316,183 | -31% | 14% | $40,104,096 |
| Point72 Asset Management, L.P. | 2.2% | 987,351 | 0.05% | $30,084,585 | |
| Driehaus Capital Management LLC | 2.2% | 956,784 | -9.6% | 0.2% | $29,153,208 |
| MILLENNIUM MANAGEMENT LLC | 2.1% | 945,461 | +19% | 0.02% | $28,808,197 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2.1% | 938,308 | -20% | 0.37% | $28,590,245 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.1% | 921,464 | +0.43% | 0% | $28,083,886 |
| STATE STREET CORP | 2% | 863,133 | +4.5% | 0% | $26,299,663 |
| Eversept Partners, LP | 1.5% | 678,262 | 1.2% | $20,666,643 | |
| Walleye Capital LLC | 1.5% | 646,539 | +9.4% | 0.11% | $19,700,043 |
| PERCEPTIVE ADVISORS LLC | 1.4% | 602,944 | +117% | 0.34% | $18,371,704 |
| Vestal Point Capital, LP | 1.4% | 600,000 | 0% | 0.67% | $18,282,000 |
| 12 West Capital Management LP | 1.3% | 575,000 | 2.1% | $17,520,250 | |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.2% | 532,749 | +9.2% | 0% | $16,233,000 |
| BANK OF AMERICA CORP /DE/ | 0.98% | 432,340 | +119% | 0% | $13,173,400 |
| LORD, ABBETT & CO. LLC | 0.98% | 430,403 | +18% | 0.04% | $13,114,000 |
| TWO SIGMA INVESTMENTS, LP | 0.93% | 410,603 | +151% | 0.02% | $12,511,073 |
Institutional Holders of Beta Bionics, Inc. - Common Stock (BBNX) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 664,531 | $6,658,595 | -$696,744 | $10.02 | 19 |
| 2025 Q4 | 47,221,203 | $1,439,219,439 | +$22,363,225 | $30.47 | 158 |
| 2025 Q3 | 48,310,134 | $959,915,542 | +$85,339,869 | $19.87 | 127 |
| 2025 Q2 | 44,848,348 | $652,883,600 | +$53,846,940 | $14.56 | 114 |
| 2025 Q1 | 41,702,710 | $507,967,865 | +$504,374,335 | $12.24 | 102 |